Prime Therapeutics wins five 2013 MarCom Awards

News provided by

Dec 11, 2013, 09:00 ET

ST. PAUL, Minn., Dec. 11, 2013 /PRNewswire/ -- For the outstanding quality and creativity of its video production and business-to-business communications, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager, received five MarCom Awards. Prime's MarCom Awards include two Platinum Awards, representing MarCom's highest honor, two Gold Awards and one honorable mention.

The winning categories included:

Platinum:

Prime Therapeutics Specialty Pharmacy™ video
Prime Therapeutics Specialty Drug Management brochure

Gold:

Prime Therapeutics PrimeMail^® brochure
Prime Therapeutics PrimeMail overview video

Honorable Mention:

Get to know Prime video

"These prestigious MarCom Awards demonstrate our efforts to create marketing tools that clearly and creatively illustrate our purpose while showcasing Prime and its specialty pharmacy and home-delivery services," said Michael Showalter, chief marketing officer at Prime. "I'm very proud that our talented team has been recognized for its compelling and on-brand creative and marketing communications."

Prime's winning entries were chosen from over 6,500 submissions from marketing and communication professionals around the world. MarCom Awards program is administered and judged by the Association of Marketing and Communication Professionals.

About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves nearly 23 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized by Modern Healthcare as one of "healthcare's hottest companies for 2013."

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.